Delve Bio

About:

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

Top Investors: Google Ventures, Xontogeny, Section 32

Description:

Delve Bio is a biotechnology business that provides molecular insights for patient precision care. Delve Bio is a biotechnology business that aims to give molecular insights for precision patient care.

Total Funding Amount:

$35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2022-01-01

Founders:

Bradley Murray, Charles Chiu, Joe DeRisi, Matthew Meyerson

Number of Employees:

1-10

Last Funding Date:

2023-06-20

IPO Status:

Private

Industries: